INNOVIVA INC (INVA) Stock News
NASDAQ:INVA - Nasdaq - US45781M1018 - Common Stock - Currency: USD
INVA Latest News, Press Relases and Analysis
Innoviva to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
INVA Stock Earnings: Innoviva Misses EPS, Beats Revenue for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Innoviva (NASDAQ:INVA) just reported results for the second quarter of 2024.Inn...
INVA Stock Earnings: Innoviva Beats EPS, Beats Revenue for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Innoviva (NASDAQ:INVA) just reported results for the first quarter of 2024.Inno...
INVA Stock Earnings: Innoviva Beats EPS, Beats Revenue for Q1 2024
INVA stock results show that Innoviva beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Innoviva to Participate in the Citi 2024 Global Healthcare Conference
Innoviva to Participate in the UBS Global Healthcare Conference
Innoviva Reports Third Quarter 2024 Financial Results; Highlights Recent Company Progress
Innoviva to Participate in Upcoming Investor Conferences
INVA Stock Earnings: Innoviva Misses EPS, Beats Revenue for Q2 2024
INVA stock results show that Innoviva missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Innoviva Reports Second Quarter 2024 Financial Results; Highlights Recent Company Progress
The 3 Most Undervalued Under-$50 Stocks to Buy in July 2024
A full-throated bull market makes it tough to find undervalued stocks under $50, but these three could soon lead the charge higher.
3 Once-in-a-Lifetime Stock Picks Due for an Unprecedented Surge
Discover three high-growth stock picks set for unprecedented surges in the metals, marine transportation, and pharmaceutical industries.
Analyst Projects Strong Growth for GSK-Innoviva Partnered Respiratory Drugs
Discover Cantor Fitzgerald's analysis on Innoviva, highlighting its unique royalty-based business model with GSK for asthma and COPD products.
Mentions: GSK
Innoviva to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
3 Under-$20 Stocks That Could Make You a Fortune
Discover three under-$20 stocks that could make a fortune in the pharmaceuticals, entertainment, and application software industries.
Innoviva Reports First Quarter 2024 Financial Results; Highlights Recent Company Progress
Innoviva to Participate in the BofA Securities Health Care Conference
Innoviva Specialty Therapeutics’ Positive Phase 3 Oral Zoliflodacin Data for the Treatment of Uncomplicated Gonorrhea Announced at ESCMID Global 2024
Armata Pharmaceuticals Announces $35 Million Secured Credit Agreement with Innoviva
/PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on pathogen-specific...
Innoviva Reports Fourth Quarter and Full Year 2023 Financial Results; Highlights Recent Company Progress
If You Can Only Buy One Biotech Stock in January, It Better Be One of These 3 Names
Biotech is one of the areas of interest in the market today, adding a biotech stock could be huge play this month.
Innoviva Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress
Positive Results Announced in Largest Pivotal Phase 3 Trial of a First-in-Class Oral Antibiotic to Treat Uncomplicated Gonorrhea
Innoviva to Participate in the Cantor Global Healthcare Conference
Innoviva names Stephen Basso as finance chief (NASDAQ:INVA)
Innoviva (INVA) said on Friday that it had appointed Stephen Basso as chief financial officer, effective August 21.More recently, Basso served as the CFO and chief operating officer...
Innoviva Appoints Stephen Basso as Chief Financial Officer
